The store will not work correctly when cookies are disabled.
(2E)-1-(5-Hydroxy-7-methoxy-2,2-dimethyl-2H-chromen-6-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one
ID: ALA4865912
PubChem CID: 15230651
Max Phase: Preclinical
Molecular Formula: C22H22O5
Molecular Weight: 366.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(/C=C/C(=O)c2c(OC)cc3c(c2O)C=CC(C)(C)O3)cc1
Standard InChI: InChI=1S/C22H22O5/c1-22(2)12-11-16-18(27-22)13-19(26-4)20(21(16)24)17(23)10-7-14-5-8-15(25-3)9-6-14/h5-13,24H,1-4H3/b10-7+
Standard InChI Key: QPRYWSHCBHNFJL-JXMROGBWSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
16.9982 -20.7645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7052 -21.1733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4118 -20.7643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4110 -19.9462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6977 -19.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9940 -19.9502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1175 -19.5355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2178 -18.7335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0350 -18.7376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6300 -18.0278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7464 -20.7746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4545 -21.1836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7476 -19.9551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4519 -19.5441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4481 -18.7332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7417 -18.3272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0396 -19.5552 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8738 -21.9989 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4543 -22.0008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1613 -19.9515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1647 -20.7722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8731 -21.1773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5828 -20.7663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8664 -19.5360 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2910 -21.1740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7465 -22.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8264 -19.9421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
9 8 1 0
10 9 1 0
13 11 2 0
11 12 1 0
12 21 2 0
20 14 2 0
13 14 1 0
13 17 1 0
14 15 1 0
15 16 2 0
16 9 1 0
9 17 1 0
22 18 2 0
12 19 1 0
20 21 1 0
20 24 1 0
21 22 1 0
22 23 1 0
23 25 2 0
25 1 1 0
19 26 1 0
7 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 366.41 | Molecular Weight (Monoisotopic): 366.1467 | AlogP: 4.49 | #Rotatable Bonds: 5 |
Polar Surface Area: 64.99 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.09 | CX Basic pKa: ┄ | CX LogP: 4.82 | CX LogD: 4.34 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.62 | Np Likeness Score: 1.69 |
References
1. Urmann C, Bieler L, Priglinger E, Aigner L, Couillard-Despres S, Riepl HM.. (2021) Neuroregenerative Potential of Prenyl- and Pyranochalcones: A Structure-Activity Study., 84 (10.0): [PMID:34542287] [10.1021/acs.jnatprod.1c00505] |